Cargando…

Cell-free DNA levels in plasma of patients with non-small-cell lung cancer and inflammatory lung disease

BACKGROUND: The analysis of plasma cell-free DNA (cfDNA) is expected to provide useful biomarkers for early diagnosis of non-small-cell lung cancer (NSCLC). However, it remains unclear whether the intense release of cfDNA into the bloodstream of NSCLC patients results from malignancy or chronic infl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Szpechcinski, A, Chorostowska-Wynimko, J, Struniawski, R, Kupis, W, Rudzinski, P, Langfort, R, Puscinska, E, Bielen, P, Sliwinski, P, Orlowski, T
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2015
Materias:	Molecular Diagnostics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4522634/ https://www.ncbi.nlm.nih.gov/pubmed/26125447 http://dx.doi.org/10.1038/bjc.2015.225

Ejemplares similares

Neoadjuvant therapy affects tumor growth markers in early stage non-small-cell lung cancer
por: Chorostowska-Wynimko, J, et al.
Publicado: (2009)

The expression of circulating miR-504 in plasma is associated with EGFR mutation status in non-small-cell lung carcinoma patients
por: Szpechcinski, Adam, et al.
Publicado: (2019)

Real-time PCR quantification of plasma DNA in non-small cell lung cancer patients and healthy controls
por: Szpechcinski, A, et al.
Publicado: (2009)

FGFR1–4 RNA-Based Gene Alteration and Expression Analysis in Squamous Non-Small Cell Lung Cancer
por: Moes-Sosnowska, Joanna, et al.
Publicado: (2022)

High levels of carbonic anhydrase IX in tumour tissue and plasma are biomarkers of poor prognostic in patients with non-small cell lung cancer
por: İlie, M, et al.
Publicado: (2010)

Unique volatolomic signatures of TP53 and KRAS in lung cells
por: Davies, M P A, et al.
Publicado: (2014)

Breast cancer metastasis suppressor-1 promoter methylation in cell-free DNA provides prognostic information in non-small cell lung cancer
por: Balgkouranidou, I, et al.
Publicado: (2014)

Restoration of TGF-β signalling reduces tumorigenicity in human lung cancer cells
por: Anumanthan, G, et al.
Publicado: (2005)

Pleural fluid analysis of lung cancer vs benign inflammatory disease patients
por: Kremer, R, et al.
Publicado: (2010)

New ARCHITECT plasma pro-gastrin-releasing peptide assay for diagnosing and monitoring small-cell lung cancer
por: Nisman, Benjamin, et al.
Publicado: (2016)

Prognostic value of microRNA expression in operable non-small cell lung cancer patients
por: Skrzypski, M, et al.
Publicado: (2014)

A multi-analyte serum test for the detection of non-small cell lung cancer
por: Farlow, E C, et al.
Publicado: (2010)

The presence of disseminated tumour cells in the bone marrow is inversely related to circulating free DNA in plasma in breast cancer dormancy
por: Payne, R E, et al.
Publicado: (2012)

Overexpression of TMPRSS4 in non-small cell lung cancer is associated with poor prognosis in patients with squamous histology
por: Larzabal, L, et al.
Publicado: (2011)

Molecular evidence of viral DNA in non-small cell lung cancer and non-neoplastic lung
por: Robinson, Lary A, et al.
Publicado: (2016)

Interleukin-1α is the major alarmin of lung epithelial cells released during photodynamic therapy to induce inflammatory mediators in fibroblasts
por: Tracy, E C, et al.
Publicado: (2012)

Gene-expression data integration to squamous cell lung cancer subtypes reveals drug sensitivity
por: Wu, D, et al.
Publicado: (2013)

Tumour cell proliferation (Ki-67) in non-small cell lung cancer: a critical reappraisal of its prognostic role
por: Warth, A, et al.
Publicado: (2014)

A microRNA-based prediction algorithm for diagnosis of non-small lung cell carcinoma in minimal biopsy material
por: Bediaga, N G, et al.
Publicado: (2013)

Prognostic significance of osteopontin expression in early-stage non-small-cell lung cancer
por: Boldrini, L, et al.
Publicado: (2005)

Combined effect of ALK and MEK inhibitors in EML4–ALK-positive non-small-cell lung cancer cells
por: Tanizaki, J, et al.
Publicado: (2012)

FADD protein release mirrors the development and aggressiveness of human non-small cell lung cancer
por: Cimino, Y, et al.
Publicado: (2012)

Clinical significance of disseminated tumour cells in non-small cell lung cancer
por: Rud, A K, et al.
Publicado: (2013)

RET-rearranged non-small-cell lung carcinoma: a clinicopathological and molecular analysis
por: Tsuta, K, et al.
Publicado: (2014)

HPV in exhaled breath condensate of lung cancer patients
por: Carpagnano, G E, et al.
Publicado: (2011)

Neuroendocrine and epithelial phenotypes in small-cell lung cancer: implications for metastasis and survival in patients
por: Stovold, R, et al.
Publicado: (2013)

Clinical value of circulating endothelial cells and of soluble CD146 levels in patients undergoing surgery for non-small cell lung cancer
por: Ilie, M, et al.
Publicado: (2014)

Cell-free and cell-bound circulating DNA in breast tumours: DNA quantification and analysis of tumour-related gene methylation
por: Skvortsova, T E, et al.
Publicado: (2006)

Pre-irradiation of mouse mammary gland stimulates cancer cell migration and development of lung metastases
por: Bouchard, G, et al.
Publicado: (2013)

The clinical significance of splice variants and subcellular localisation of survivin in non-small cell lung cancers
por: Nakano, J, et al.
Publicado: (2008)

Expression of a disintegrin and metalloprotease (ADAM and ADAMTS) enzymes in human non-small-cell lung carcinomas (NSCLC)
por: Rocks, N, et al.
Publicado: (2006)

TGFBI expression is an independent predictor of survival in adjuvant-treated lung squamous cell carcinoma patients
por: Pajares, M J, et al.
Publicado: (2014)

Haemoptysis as a prognostic factor in lung adenocarcinoma after curative resection
por: Hu, P, et al.
Publicado: (2013)

Serum LAMC2 enhances the prognostic value of a multi-parametric panel in non-small cell lung cancer
por: Korbakis, D, et al.
Publicado: (2015)

Detailed analysis of inflammatory cell infiltration in colorectal cancer
por: Väyrynen, J P, et al.
Publicado: (2013)

Prognostic role of FGFR1 amplification in early-stage non-small cell lung cancer
por: Cihoric, N, et al.
Publicado: (2014)

Molecular characterisation of side population cells with cancer stem cell-like characteristics in small-cell lung cancer
por: Salcido, C D, et al.
Publicado: (2010)

Detection of K-Ras mutations in tumour samples of patients with non-small cell lung cancer using PNA-mediated PCR clamping
por: Beau-Faller, M, et al.
Publicado: (2009)

DNA hypermethylation analysis in sputum for the diagnosis of lung cancer: training validation set approach
por: Hubers, A J, et al.
Publicado: (2015)

Comprehensive epidermal growth factor receptor gene analysis from cytological specimens of non-small-cell lung cancers
por: Savic, S, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_65c0uhnvivft8ve9lpfg3uu6rq